Changes in Mood, Anxiety, and Cognition with Polycystic Ovary Syndrome Treatment: A Longitudinal, Naturalistic Study.

Sukhapure, Mayouri; Eggleston, Kate; Fenton, Anna; Frampton, Christopher; Porter, Richard J; Douglas, Katie M

Sukhapure, Mayouri; Eggleston, Kate; Fenton, Anna; Frampton, Christopher; Porter, Richard J; Douglas, Katie M.

Afiliación

Sukhapure M; Department of Psychological Medicine, University of Otago, Christchurch, Canterbury, New Zealand.
Eggleston K; Centre for Healthy Brain Ageing, University of New South Wales, Sydney, New South Wales, Australia.
Fenton A; Department of Psychological Medicine, University of Otago, Christchurch, Canterbury, New Zealand.
Frampton C; Specialist Mental Health Services, Canterbury District Health Board, Christchurch, Canterbury, New Zealand.
Porter RJ; Department of Endocrinology, Canterbury District Health Board, Christchurch, Canterbury, New Zealand.
Douglas KM; Oxford Women's Health, Christchurch, Canterbury, New Zealand.

Neuropsychiatr Dis Treat ; 18: 2703-2712, 2022.

Article en En | MEDLINE | ID: mdl-36411778

Palabras clave

androgen; cognitive function; depression; spironolactone; testosterone

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Neuropsychiatr Dis Treat Año: 2022 Tipo del documento: Article País de afiliación: Nueva Zelanda Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google